Regulation 25 Provision of information about costs incurred in connection with the manufacture or distribution of a particular health service medicine or appliance
If the Secretary of State requires the information for the statutory purpose, the Secretary of State may by information notice M1 require a UK producer to provide specified information in respect of any relevant costs incurred by the producer—
in connection with the manufacturing of a particular presentation of unbranded generic health service medicine or special health service medicine;
in connection with the distribution or supply of a particular presentation of health service medicine;
in connection with the manufacturing, supply or distribution of a particular appliance which—
is a UK health service product, and
is, in the month in which the request is made, listed in a Drug Tariff.
But the Secretary of State may not require a UK producer to provide any information which the producer could not reasonably be expected to record and keep for the purpose of understanding the producer's relevant costs.
An information notice must specify the statutory purpose for which the specified information is required.
A UK producer must comply with any information notice given to the producer.
In this regulation—
“relevant costs”, in relation to a producer, means any costs (including, for example, manufacturing costs, supply costs, distribution costs, research and development cost, capital costs and business costs) other than costs which relate to any transaction between the producer and a UK producer for the relevant health service product;
“specified” means specified in an information notice.
Annotations
Marginal citations
- M1
See the definition of “information notice” in section 264A(6) of the National Health Service Act 2006.